Who was studied, and how
Two numbers in the abstract
Where each one falls
Where it lands on the map
What it changes
Among 23 other studies
people with obesity, in this paper
The trial randomly assignedassigned by chance
liraglutide
usual care
No clear effect on serious adverse events+0.09
randomisedThe trial randomly assignedassigned by chance
semaglutide
usual care
No clear effect on serious adverse events+0.21
randomisedthe abstract, start to end
… of adverse events, with liraglutide (0.09, 95% CI - 0.74, 0.92) and semaglutide (0.21, 95% CI - 0.46, 0.88) also …
← favours treatmentfavours comparator →
could be chanceIncidence of serious adverse eventsliraglutide vs usual care
0.09−0.74 to 0.92
Incidence of serious adverse eventssemaglutide vs usual care
0.21−0.46 to 0.88
GLP-1 receptor agonistsAdverse events & safety
GLP-1 receptor agonists × adverse events & safetyharms?mixed
unlikelylikely
0.02not counted
← favours treatmentfavours comparator →
1 / 6